The global AI in diagnostics Market is anticipated to grow at a CAGR of 23. 5% during the forecast period (2023–2030). Machine learning (ML) algorithms offers the capability to track and monitor patient symptoms and notify medical personnel/ staff about potential risks. The utilization of AI algorithms enhances the precision of medical diagnosis, improve patient outcomes, and enhance healthcare efficiency by analyzing huge amounts of medical data, and establishing connections. AI-powered applications are designed to scrutinize patient data, medical images, and clinical guidelines, providing indispensable support to healthcare professionals in making precise disease diagnoses and determining optimal treatment plans. AI is particularly effective in medical imaging analysis, providing precise and efficient evaluations of X-rays, MRIs, and CT scans.
Browse the full report description of “Artificial Intelligence (AI) in Diagnostics Market Size, Share & Trends Analysis Report by Type (Vitro Diagnostics, and Diagnostic Imaging), by Application (Cardiology, Oncology, Neurology, Obstetrics and Gynecology, and Others), and by End User (Hospitals, Diagnostics Imaging Centers, and Diagnostics Laboratories), Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/ai-in-diagnostics-market
The growth of the market is attributed to growing data volumes around the globe. The healthcare sector generates enormous amounts of data, including patient information and medical images. AI is capable of processing and analyzing this data, surpassing the capabilities of human experts. Consequently, market players are innovating new offerings to address the surging demand for imaging networks. For instance, in November 2021, Nuance Communications Inc. launched the Nuance Precision Imaging Network, an AI-driven cloud platform that integrates patient-specific data and insights from diagnostic imaging into current clinical and administrative procedures throughout the healthcare ecosystem. The Nuance Precision Imaging Network connects imaging consumers, facilitating AI to inform precision diagnostics and therapeutics, increase physician efficiency, and reduce overall healthcare expenses. Leveraging the capabilities of Nuance's PowerScribe and Power Share diagnostic imaging solutions, this initiative represents the industry’s commitment to joining AI’s potential for substantial advancements in healthcare.
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Type
o By Application
o By End User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- includes Aidoc Medical Ltd., Digital Diagnostics Inc., IMAGEN, InformAI, LLC, Nano-x Imaging Ltd., and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Artificial Intelligence (AI) in Diagnostics Market Report Segment
By Type
By Application
By End User
Global Artificial Intelligence (AI) in Diagnostics Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/ai-in-diagnostics-market